Top

Osteoporosis International

Published in:

01-09-2011 | Original Article

Utility of automated data in identifying femoral shaft and subtrochanteric (diaphyseal) fractures

Authors: L. Spangler, S. M. Ott, D. Scholes

Published in: Osteoporosis International | Issue 9/2011

Abstract

Summary

In women age 45 years and older, enrolled in an integrated group practice in 2007, use of ICD9 diagnostic codes, including the “not otherwise specified” code (821.00) resulted in a high false-positive rate for identifying femoral diaphyseal fractures. Restriction to more specific site-codes missed 36% of these rare fractures.

Introduction

The aim of this study was to assess the utility of automated data in identifying the occurrence of femoral diaphyseal fractures.

Methods

We identified all women age 45 years and older enrolled in a Pacific Northwest integrated group practice during 2007. Using the computerized database we selected all ICD9 codes that could be related to a femur fracture occurring in the diaphyseal region. We then quantified the percent of codes confirmed by medical record review to have occurred in the correct anatomic location during the year of interest (positive predictive value).

Results

Of the 95,765 eligible women, 161 (0.17%) had an ICD9 diagnostic code potentially related to a femoral diaphyseal fracture in 2007; of these 58 (36%) had a fracture of the femoral diaphysis, and 38 (24%) of the fractures occurred in 2007. The most frequent code was 821.00, described as “femur fracture not otherwise specified”, applied to 107 women; 21 of the 58 diaphyseal fractures had this code.

Conclusion

In this study, use of ICD9 codes that included the “not otherwise specified” code (821.00) resulted in a high false-positive rate for identifying diaphyseal fractures. However, restriction to more specific site codes would have missed at least 36% of the diaphyseal fractures. Furthermore, the codes did not provide any information about the characteristics of the fracture. Our findings support validating cases selected using ICD codes before they are used as a surrogate for the occurrence of femoral diaphyseal fractures.

FDA USFDA (2010) FDA Drug Safety Communication: Ongoing safety review of oral bisphosphonates and atypical subtrochanteric femur fractures. Silver Spring, MD

Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, Cauley J, Leung PC, Boonen S, Santora A, de Papp A, Bauer DC, The Fracture Intervention T, Committees HPFTS (2010) Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. doi:10.1056/NEJMoa1001086

Ray WA, Griffin MR, Fought RL, Adams ML (1992) Identification of fractures from computerized Medicare files. J Clin Epidemiol 45:703–714.PubMedCrossRef

Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG (2008) Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 22:346–350. doi:10.1097/BOT.0b013e318172841c PubMedCrossRef

De Das S, Setiobudi T, Shen L (2010) A rational approach to management of alendronate-related subtrochanteric fractures. J Bone Joint Surg Br 92:679–686. doi:10.1302/0301-620X.92B5.22941 CrossRef

Girgis CM, Sher D, Seibel MJ (2010) Atypical femoral fractures and bisphosphonate use. N Engl J Med 362:1848–1849. doi:10.1056/NEJMc0910389 PubMedCrossRef

Lenart BA, Neviaser AS, Lyman S, Chang CC, Edobor-Osula F, Steele B, van der Meulen MC, Lorich DG, Lane JM (2008) Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int. doi:10.1007/s00198-008-0805-x PubMed

Abrahamsen B, Eiken P, Eastell R (2008) Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. J Bone Miner Res. doi:10.1359/jbmr.081247

Nieves JW, Bilezikian JP, Lane JM, Einhorn TA, Wang Y, Steinbuch M, Cosman F (2009) Fragility fractures of the hip and femur: incidence and patient characteristics. Osteoporos Int. doi:10.1007/s00198-009-0962-6 PubMed

10.

Evans JG (1979) Fractured proximal femur in Newcastle upon Tyne. Age Ageing 8:16–24PubMedCrossRef

11.

Fisher ES, Whaley FS, Krushat WM, Malenka DJ, Fleming C, Baron JA, Hsia DC (1992) The accuracy of Medicare's hospital claims data: progress has been made, but problems remain. Am J Public Health 82:243–248PubMedCrossRef

12.

Nevitt MC, Cummings SR, Browner WS, Seeley DG, Cauley JA, Vogt TM, Black DM (1992) The accuracy of self-report of fractures in elderly women: evidence from a prospective study. Am J Epidemiol 135:490–499PubMed

13.

Ismail AA, O'Neill TW, Cockerill W, Finn JD, Cannata JB, Hoszowski K, Johnell O, Matthis C, Raspe H, Raspe A, Reeve J, Silman AJ (2000) Validity of self-report of fractures: results from a prospective study in men and women across Europe. EPOS Study Group. European Prospective Osteoporosis Study Group. Osteoporos Int 11:248–254PubMedCrossRef

14.

Hundrup YA, Hoidrup S, Obel EB, Rasmussen NK (2004) The validity of self-reported fractures among Danish female nurses: comparison with fractures registered in the Danish National Hospital Register. Scand J Public Health 32:136–143PubMedCrossRef

15.

Beard CM, Melton LJ 3rd, Cedel SL, Richelson LS, Riggs BL (1990) Ascertainment of risk factors for osteoporosis: comparison of interview data with medical record review. J Bone Miner Res 5:691–699. doi:10.1002/jbmr.5650050705 PubMedCrossRef

16.

Chan KA, Andrade SE, Boles M, Buist DS, Chase GA, Donahue JG, Goodman MJ, Gurwitz JH, LaCroix AZ, Platt R (2000) Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet 355:2185–2188. doi:10.1016/S0140-6736(00)02400-4 PubMedCrossRef

17.

Shatin D (2001) Organizational context and taxonomy of health care databases. Pharmacoepidemiol Drug Saf 10:367–371. doi:10.1002/pds.606 PubMedCrossRef

18.

Hennekens CH, Buring JE (1987) Screening. In: Mayrent SL (ed) Epidemiology in medicine. Little, Brown and Company, Boston/Toronto, pp 327–347

Title: Utility of automated data in identifying femoral shaft and subtrochanteric (diaphyseal) fractures
Authors: L. Spangler
S. M. Ott
D. Scholes
Publication date: 01-09-2011
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 9/2011
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-010-1476-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Utility of automated data in identifying femoral shaft and subtrochanteric (diaphyseal) fractures

Abstract

Summary

Introduction

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 9/2011

Hip fracture incidence in Lebanon: a national registry-based study with reference to standardized rates worldwide

Lifestyle factors, medications, and disease influence bone mineral density in older men: findings from the CHAMP study

Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram: rejoinder to comments by Pluskiewicz and Drozdzowska

Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON–Recurrent Fracture Trial

Guidelines for conducting and reporting economic evaluation of fall prevention strategies

Erratum to: Sunlight and dietary contributions to the seasonal vitamin D status of cohorts of healthy postmenopausal women living at northerly latitudes: a major cause for concern?